Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C4H11NO.C4H6O6 |
| Molecular Weight | 239.2231 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCO.O[C@H]([C@@H](O)C(O)=O)C(O)=O
InChI
InChIKey=UIEGYKVRCKDVKQ-LREBCSMRSA-N
InChI=1S/C4H11NO.C4H6O6/c1-5(2)3-4-6;5-1(3(7)8)2(6)4(9)10/h6H,3-4H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
| Molecular Formula | C4H6O6 |
| Molecular Weight | 150.0868 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C4H11NO |
| Molecular Weight | 89.1362 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DEANOL is an inactive component of CERAVE® hydrocortisone anti-itch cream, which is used for temporarily relieve itching associated with minor skin irritations, inflammation, and rashes due to eczema, soaps, detergents, cosmetics, seborrheic dermatitis, psoriasis. DEANOL is also used as a food additive.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % single, topical Highest studied dose Dose: 0.1 % Route: topical Route: single Dose: 0.1 % Sources: Page: p.10 |
healthy Health Status: healthy Sources: Page: p.10 |
|
6000 mg 1 times / day multiple, oral Highest studied dose Dose: 6000 mg, 1 times / day Route: oral Route: multiple Dose: 6000 mg, 1 times / day Sources: Page: p.188 |
unhealthy Health Status: unhealthy Condition: Involuntary movement disorders Sources: Page: p.188 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. | 2001 Aug |
|
| Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. | 2002 Apr |
|
| Efficacy of dimethylaminoethanol (DMAE) containing vitamin-mineral drug combination on EEG patterns in the presence of different emotional states. | 2003 May 30 |
|
| The role of dimethylaminoethanol in cosmetic dermatology. | 2005 |
|
| A new design strategy for dispersion stabilization of Ni particles based on the surface acid and base properties of Ni particles. | 2007 Aug 15 |
|
| Dimethylaminoethanol affects the viability of human cultured fibroblasts. | 2007 Nov-Dec |
|
| Strong intramolecular Si-N interactions in the chlorosilanes Cl3-nHnSiOCH2CH2NMe2 (n = 1-3). | 2008 Nov 17 |
|
| Efficient automated one-step synthesis of 2-[18F]fluoroethylcholine for clinical imaging: optimized reaction conditions and improved quality controls of different synthetic approaches. | 2010 Apr |
|
| Mesotherapy - The french connection. | 2010 Jan |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:21:29 GMT 2023
by
admin
on
Fri Dec 15 15:21:29 GMT 2023
|
| Record UNII |
D240J05W14
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 331.15
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
236124
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | RxNorm | ||
|
D240J05W14
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
100000089061
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
SUB01561MIG
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
DTXSID40952332
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
m4115
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB62020
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
16212495
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
D240J05W14
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
227-809-3
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY | |||
|
5988-51-2
Created by
admin on Fri Dec 15 15:21:30 GMT 2023 , Edited by admin on Fri Dec 15 15:21:30 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |